Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Peptide Modification Diminishes HLA Class II-restricted CD4+ T Cell Recognition of Prostate Cancer Cells.
Journal: International journal of molecular sciences
Published: October 22, 2022
Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 18, 2015
Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.
Journal: Immunology
Published: December 18, 2013
Showing 1-4 of 4
Last Updated: 09/26/2026